Kimberly-Clark Co. (NYSE:KMB) Insider Sells $866,420.10 in Stock

Kimberly-Clark Co. (NYSE:KMBGet Free Report) insider Jeffrey P. Melucci sold 6,390 shares of the company’s stock in a transaction dated Monday, April 29th. The stock was sold at an average price of $135.59, for a total value of $866,420.10. Following the sale, the insider now owns 33,649 shares in the company, valued at approximately $4,562,467.91. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Kimberly-Clark Trading Down 0.0 %

NYSE:KMB opened at $136.47 on Thursday. The stock’s 50 day moving average price is $126.88 and its 200 day moving average price is $123.24. The company has a market capitalization of $45.95 billion, a PE ratio of 25.09, a P/E/G ratio of 3.87 and a beta of 0.40. The company has a quick ratio of 0.54, a current ratio of 0.81 and a debt-to-equity ratio of 6.05. Kimberly-Clark Co. has a 52-week low of $116.32 and a 52-week high of $147.02.

Kimberly-Clark (NYSE:KMBGet Free Report) last posted its quarterly earnings data on Tuesday, April 23rd. The company reported $2.01 earnings per share for the quarter, topping analysts’ consensus estimates of $1.61 by $0.40. Kimberly-Clark had a return on equity of 250.28% and a net margin of 9.05%. The company had revenue of $5.15 billion during the quarter, compared to analysts’ expectations of $5.08 billion. During the same period last year, the firm earned $1.67 EPS. The firm’s revenue for the quarter was down .9% on a year-over-year basis. On average, research analysts anticipate that Kimberly-Clark Co. will post 7 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Barclays upped their price target on Kimberly-Clark from $132.00 to $136.00 and gave the stock an “equal weight” rating in a report on Thursday, April 25th. JPMorgan Chase & Co. increased their price objective on Kimberly-Clark from $115.00 to $123.00 and gave the company an “underweight” rating in a report on Wednesday, April 24th. HSBC increased their price objective on Kimberly-Clark from $146.00 to $150.00 and gave the company a “hold” rating in a report on Wednesday, April 24th. Piper Sandler increased their price objective on Kimberly-Clark from $145.00 to $152.00 and gave the company an “overweight” rating in a report on Thursday, March 28th. Finally, Deutsche Bank Aktiengesellschaft increased their price objective on Kimberly-Clark from $127.00 to $132.00 and gave the company a “hold” rating in a report on Thursday, March 28th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $134.85.

Get Our Latest Stock Analysis on Kimberly-Clark

Institutional Trading of Kimberly-Clark

Hedge funds have recently added to or reduced their stakes in the stock. Rise Advisors LLC lifted its position in Kimberly-Clark by 926.3% during the 1st quarter. Rise Advisors LLC now owns 195 shares of the company’s stock worth $25,000 after acquiring an additional 176 shares during the period. Accordant Advisory Group Inc acquired a new stake in shares of Kimberly-Clark in the 1st quarter valued at approximately $27,000. Cranbrook Wealth Management LLC lifted its holdings in shares of Kimberly-Clark by 90.9% in the 4th quarter. Cranbrook Wealth Management LLC now owns 210 shares of the company’s stock valued at $26,000 after buying an additional 100 shares during the period. OFI Invest Asset Management acquired a new stake in shares of Kimberly-Clark in the 3rd quarter valued at approximately $25,000. Finally, Centerpoint Advisors LLC lifted its holdings in shares of Kimberly-Clark by 175.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 275 shares of the company’s stock valued at $33,000 after buying an additional 175 shares during the period. 76.29% of the stock is owned by institutional investors and hedge funds.

Kimberly-Clark Company Profile

(Get Free Report)

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.

Featured Articles

Insider Buying and Selling by Quarter for Kimberly-Clark (NYSE:KMB)

Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.